$ EPGL Twitter Update Complete Jan 20-22 2016 #IoT #WearableTechnology
EPGLMed: To potential EPGL Investors who have not taken a position yet, Here's the bet you are making by investing in EPGL: In 2013 and and 2014, tiny EPGL and Large CooperVision, Inc. teamed up in a Development Agreement. As EPGL team began to prove to in CooperVision R&D head, Dr. Arthur Back, that our innovations actually worked in real, modern, mass produceable, Silicone Hydrogel lenses, CooperVision then signed EPGL to a Second Development Agreement that was bigger and more comprehensive of all EPGL technologies. Joint IP, as a result of the proven concepts, then began to be filed.
Those jointly developed patents originated from experimentation in real-world CooperVision, Inc. manufacturing facilities. We have strong reason to believe that neither Google nor Alcon/Novartis was ahead of EPGL/CooperVision. Nothing is promised, but that is what our best knowledge is.
The potential market for Autofocus enabled contact lenses alone is $5B + annual. The market for other combined vision enhancements and potential AR applications is estimated by top CEO's in technology to be worth $100B.
So, as a potential investor, you are making the bet that tiny EPGL who (through settlement negotiations ) has now gained 100% ownership and control, while allowing CooperVision to be the FIRST to have license, has pending patents that in some cases could "run the table" of this massive potential market if granted.
That is the bet YOU are making if you go long-EPGL, if this tiny OTC is on to something very big as we believe we are. And don't let idiots on anonymous websites like Ihub etc. try to tell you this situation is too good to be true, because what has just been laid -out for you is the facts, backed by independent documents
So, you decide, after doing due diligence and reading all materials. EPGL is only at 3 cents currently due to low volume moves. The volatility works both ways however. EPGL has a chart history of big gains over time and rising back to pass previous highs. In summary, with our NEW Ownership of the pending patents and WORLDWIDE rights, EPGL is better positioned than ever for growth from IP licensing and partnerships if ONLY ONE of the jointly developed patents we have filed and is pending presently, gets approval, those who use it will have to pay EPGL royalties, whether or not we have a formal license Agreement with them.
The bet? The bet is on IP that may pay-off big if granted and if the coming Vision Revolution is as big as predicted. Literally all things now on your smartphone, are being predicted to be and if the coming Vision Revolution is as big as predicted made available in your field of vision. Think that is big? Good luck with whatever bet you make on EPGL!
Michael Hayes & Dr. Markus at Intel HQ for meeting in 2014 .
Michael Hayes, Dr. David Markus & Dr. Arthur Back at CooperVision, Inc. "Inventing the future of vision."
Michael Hayes and Gavin Rossdale about to watch Federer and Djokavic play in CA.
Michael Hayes and Dr. David Markus in San Francisco.
EPGL and CooperVision, Inc. are not "done" at all. The parties must continue to adhere to their latest Agreement which governs rights and ownership of the jointly developed technologies. This arrangement will go on for years. EPGL intends for CooperVision to be only one of many companies to have license to our newfound ownership and control of the technology. In fact, EPGL is now in process of implementing new plans that will begin to become visible within the next 14 days. Our last PR was misunderstood by many. EPGLs position and potential is now stronger than ever before with what we have gained. 2016 is truly the new beginning. NEW PATENTS PENDING. NEW OWNERSHIP & CONTROL. NEW WORLDWIDE MARKETING RIGHTS. 3 reasons why EPGL is a player in the coming VISION REVOLUTION!
https://twitter.com/EPGLMed
EPGLMed: To potential EPGL Investors who have not taken a position yet, Here's the bet you are making by investing in EPGL: In 2013 and and 2014, tiny EPGL and Large CooperVision, Inc. teamed up in a Development Agreement. As EPGL team began to prove to in CooperVision R&D head, Dr. Arthur Back, that our innovations actually worked in real, modern, mass produceable, Silicone Hydrogel lenses, CooperVision then signed EPGL to a Second Development Agreement that was bigger and more comprehensive of all EPGL technologies. Joint IP, as a result of the proven concepts, then began to be filed.
Those jointly developed patents originated from experimentation in real-world CooperVision, Inc. manufacturing facilities. We have strong reason to believe that neither Google nor Alcon/Novartis was ahead of EPGL/CooperVision. Nothing is promised, but that is what our best knowledge is.
The potential market for Autofocus enabled contact lenses alone is $5B + annual. The market for other combined vision enhancements and potential AR applications is estimated by top CEO's in technology to be worth $100B.
So, as a potential investor, you are making the bet that tiny EPGL who (through settlement negotiations ) has now gained 100% ownership and control, while allowing CooperVision to be the FIRST to have license, has pending patents that in some cases could "run the table" of this massive potential market if granted.
That is the bet YOU are making if you go long-EPGL, if this tiny OTC is on to something very big as we believe we are. And don't let idiots on anonymous websites like Ihub etc. try to tell you this situation is too good to be true, because what has just been laid -out for you is the facts, backed by independent documents
So, you decide, after doing due diligence and reading all materials. EPGL is only at 3 cents currently due to low volume moves. The volatility works both ways however. EPGL has a chart history of big gains over time and rising back to pass previous highs. In summary, with our NEW Ownership of the pending patents and WORLDWIDE rights, EPGL is better positioned than ever for growth from IP licensing and partnerships if ONLY ONE of the jointly developed patents we have filed and is pending presently, gets approval, those who use it will have to pay EPGL royalties, whether or not we have a formal license Agreement with them.
The bet? The bet is on IP that may pay-off big if granted and if the coming Vision Revolution is as big as predicted. Literally all things now on your smartphone, are being predicted to be and if the coming Vision Revolution is as big as predicted made available in your field of vision. Think that is big? Good luck with whatever bet you make on EPGL!
Michael Hayes & Dr. Markus at Intel HQ for meeting in 2014 .
Michael Hayes, Dr. David Markus & Dr. Arthur Back at CooperVision, Inc. "Inventing the future of vision."
Michael Hayes and Gavin Rossdale about to watch Federer and Djokavic play in CA.
Michael Hayes and Dr. David Markus in San Francisco.
EPGL and CooperVision, Inc. are not "done" at all. The parties must continue to adhere to their latest Agreement which governs rights and ownership of the jointly developed technologies. This arrangement will go on for years. EPGL intends for CooperVision to be only one of many companies to have license to our newfound ownership and control of the technology. In fact, EPGL is now in process of implementing new plans that will begin to become visible within the next 14 days. Our last PR was misunderstood by many. EPGLs position and potential is now stronger than ever before with what we have gained. 2016 is truly the new beginning. NEW PATENTS PENDING. NEW OWNERSHIP & CONTROL. NEW WORLDWIDE MARKETING RIGHTS. 3 reasons why EPGL is a player in the coming VISION REVOLUTION!
https://twitter.com/EPGLMed
